GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Clinical Laboratory Tests Market is Segmented By Test Type (Complete Blood Count, Hgb/ Hct Testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, Hba1c Testing, Comprehensive Metabolic Panel, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Others), By Application (Parasitology, Virology, Hematology, Toxicology, Immunology/serology, Histopathology And Urinalysis), By End User (Central Laboratories, Hospital Laboratories, Independent Laboratories, Research and Academia), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024
Code : CMI6546
Pages :172
Formats :
Excel and PDF
Industry : Pharmaceutical

Global Clinical Laboratory Tests Market Size and Trends

Global clinical laboratory market size is expected to reach US$ 317.5 Bn by 2030, from US$ 241.9 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 4% during the forecast period.

Market- Trends

Technological Advancement such as In-vitro Diagnostics: Technological advancements in the field of in-vitro diagnostics have revolutionized clinical pathology tests in recent years. Introduction of automated, high-throughput solutions have made testing faster, more accurate and affordable. Automated analyzers, microfluidics based solutions, point-of-care (POC) testing devices and molecular diagnostic platforms are helping clinicians to obtain diagnostic information quickly and facilitate prompt treatment decisions. Adoption of advanced testing methods like immunohistochemistry, flow cytometry, genetic testing, and others have expanded testing options well beyond traditional clinical chemistry and immunoassays. Transition from centralized labs to decentralized and modular testing set-ups through lab automation is supporting increased accessibility in rural areas as well. Developments in data analytics are further enabling laboratories to streamline operations and report results efficiently. Continued innovation in diagnostic technologies ensures that lab testing remains an integral part of patient management, thereby augmenting demand in the overall clinical laboratory tests industry.